Biosimilarity

Discover the intricacies of biosimilar drug approval with Biosimilarity by Sarfaraz Niazi, published by Taylor & Francis Ltd in 2023. This comprehensive paperback spans 436 pages, providing an in-depth analysis of the US FDA's approach to biosimilar drugs. While the European market has established specific guidelines for biosimilars, Niazi highlights the unique considerations and regulatory frameworks that the FDA employs in its approval process. This book is an essential resource for pharmacy professionals, researchers, and anyone interested in the evolving landscape of biosimilars. Gain valuable insights into the regulatory challenges and opportunities that shape the future of biosimilar therapeutics. Enhance your understanding of this critical subject matter with Biosimilarity, a pivotal addition to your professional library.